Health Blog : FDA Delays Decision on Wyeth Menopause Drug: "The FDA said late yesterday it wasn’t ready to approve Pristiq, a drug derived from Wyeth’s antidepressant Effexor XR and intended to treat hot flashes and other symptoms of menopause, the WSJ reports.
The FDA told Wyeth to do a year-long study of the drug to see whether it is associated serious cardiovascular or liver problems, the company said this morning.
In trials, Pristiq has caused nausea and other side effects. And there have been a few signs that it may raise the risk of cardiovascular problems."
